Trevena, Inc. (TRVN)
Current
- (-)
After Hours
Rating Performance
Rating Return
+0.0% vs
Rating Accuracy
0.0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0.0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0.0% (0 of 0*)
Rating Return
-20.06% vs
Rating Accuracy
0.0% (0 of 2*)
FV Performance
FV Accuracy
0 Hits (0.0% Hit Rate)
FV Avg. Distance
+0.0%
FV Accuracy
0 Hits (0.0% Hit Rate)
FV Avg. Distance
+168.31%
FV Accuracy
1 Hit (4.0% Hit Rate)
FV Avg. Distance
+77.72%
FV Accuracy
26 Hits (53.06% Hit Rate)
FV Avg. Distance
+30.1%
About
CEO
Carrie L. Bourdow
Employees
24
Industry
Pain Management Biopharmaceuticals
Sector
Healthcare
Headquarters
Chesterbrook
Exchange
NASDAQ
Website
http://www.trevenainc.comSummary Stats
Market Cap
41M
Revenue
-
Net Income
-
EPS
$0.00
Price-to-Earnings
-
Price-to-Book
-
Debt-to-Equity
-
News
Analyst Ratings
Price targets projected by 4 analysts
High
$6.00
Average
$5.25
Low
$5.00
Ratings calculated by 0 analysts
Buy
0
Hold
0
Sell
0
Last Dividend
Amount
-
Dividend Date
-
Frequency
-
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q1 2022
Not Available
-$0.10 -
-
-0.06
Down 66%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--